Prognosis of early breast cancer has been greatly improved in the
last four decades
• Landmark trials of adjuvant tamoxifen
• 1970s and 1980s; combination chemotherapy
• Since then, ever more intense and complex regimens, containing a
combination of cytotoxic agents, endocrine agents and/or targeted
agents have become the norm for hundreds of thousands of women
.
19-9-2017




